ClinicalTrials.gov
public full text
Public Domain
Metformin for Abdominal Aortic Aneurysm Growth Inhibition
A multi-centre population-based open-label randomized controlled trial with allocation concealment and blinded outcome assessment will examine if up to 2g metformin daily slows AAA growth in patients with small AAAs who do not have diabetes.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of the Large Diameter GORE EXCLUDER® AAA Endoprosthesis in Abdominal Aneurysms#907028
- Growth rate, diameter at rupture, and associated patient characteristics of abdominal aortic aneurysms without an intraluminal thrombus.#480845
- ACZ885 for the Treatment of Abdominal Aortic Aneurysm#885474
- Young Patient With Aortic Dissection or Aneurysm: A Prospective Observational Cohort Study#1127087
- Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial#1127449
Record · ID 916360
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive